LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 72 filers reported holding LEAP THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,524,694 | +902.4% | 7,425,570 | +1226.7% | 0.01% | +600.0% |
| Q4 2022 | $251,867 | -48.9% | 559,705 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $493,000 | -23.4% | 559,705 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $644,000 | -34.2% | 559,705 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $979,000 | -46.0% | 559,705 | 0.0% | 0.01% | -33.3% |
| Q4 2021 | $1,813,000 | -19.2% | 559,705 | 0.0% | 0.01% | -10.0% |
| Q3 2021 | $2,244,000 | +144.4% | 559,705 | 0.0% | 0.01% | +150.0% |
| Q2 2021 | $918,000 | -13.6% | 559,705 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $1,063,000 | -15.6% | 559,705 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $1,259,000 | +13.6% | 559,705 | 0.0% | 0.01% | +25.0% |
| Q3 2020 | $1,108,000 | -45.8% | 559,705 | -42.8% | 0.00% | -55.6% |
| Q2 2020 | $2,045,000 | +32.3% | 978,454 | 0.0% | 0.01% | -10.0% |
| Q1 2020 | $1,546,000 | +41.1% | 978,454 | 0.0% | 0.01% | +66.7% |
| Q4 2019 | $1,096,000 | -4.3% | 978,454 | 0.0% | 0.01% | -25.0% |
| Q3 2019 | $1,145,000 | – | 978,454 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 2,664,400 | $2,345,000 | 2.45% |
| Key Client Fiduciary Advisors, LLC | 1,120,943 | $986,000 | 0.89% |
| Knott David M Jr | 900,000 | $792,000 | 0.33% |
| ACT CAPITAL MANAGEMENT, LLC | 265,000 | $233,000 | 0.32% |
| Perceptive Advisors | 7,472,148 | $6,575,000 | 0.19% |
| Tri Locum Partners LP | 711,798 | $626,000 | 0.17% |
| 683 Capital Management, LLC | 2,265,000 | $1,993,000 | 0.15% |
| Artal Group S.A. | 4,000,000 | $3,520,000 | 0.15% |
| TANG CAPITAL MANAGEMENT LLC | 1,250,000 | $1,100,000 | 0.14% |
| HealthCor Management, L.P. | 1,066,689 | $939,000 | 0.12% |